The incidence of target-lesion revascularization was 6.5, 9.0, and 10.2% at 6, 12 and 24 months, respectively. The MELODIE trial also demonstrated the safety of iliac artery revascularization with ...

Wearable devices can reduce cardiovascular events and death in ischemic heart disease, according to a new meta-analysis, but ...

Adapted from: Andersen BK. Quantitative flow ratio or fractional flow reserve for guiding coronary revascularization. Presented at: TCT 2024. Washington, DC. Patients whose coronary revascularization ...

The following is a summary of “Effects of Novel Antidiabetic Agents on Contrast-Associated Acute Kidney Injury in Diabetic Patients Undergoing Percutaneous Coronary Intervention,” published in the ...

A new therapeutic device, the Coronary Sinus Reducer (CSR), is making waves in the treatment of refractory angina, providing ...